טוען...
Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
BACKGROUND: Neutralizing anti-drug antibodies (NAbs) to interferon beta (IFNβ) develop in up to 47% of multiple sclerosis (MS) treated patients inhibiting treatment effect of IFNβ. However, the long-term effect of NAbs remain unknown. OBJECTIVE: To investigate the long-term consequences of high tite...
שמור ב:
| הוצא לאור ב: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7593513/ https://ncbi.nlm.nih.gov/pubmed/33178215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.583560 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|